AGARWALEYENSEDr. Agarwal's Health Care Limited· Healthcare ServicesHighPositive
Announced Mon, 11 May, 2026 · 17:51 IST

Dr. Agarwal's Health Care Limited has informed the Exchange about the Receipt of Order passed by the Hon ble NCLT, Chennai Bench, in relation to the Scheme of amalgamation between Dr. Agarwal s Eye Hospital Limited and Dr. Agarwal s Health Care Limited

AGARWALEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.5%Reaction day
₹464.80
prior close
₹460.85
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-3.1%+0.5% vs market
Hospital peers, median of 24sector-2.3%-0.3% vs sector

On the reaction day the stock moved 0.5 pts more than Nifty Microcap 250 and 0.3 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.1
10m
-0.2
15m
-0.4
30m
+0.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.5-3.1+0.5-2.3-0.3
Next day
-3.2-2.4-0.8-1.8-1.4
2d
-4.3-2.2-2.1-1.4-2.8
3d
-3.0-2.5-0.5-1.5-1.6
4d
-5.3-3.8-1.4-2.5-2.8
5d
-2.3-3.4+1.1-1.0-1.3
1w
+3.7-1.8+5.5-0.9+4.6
15d
-0.9+0.1-1.0-2.5+1.5
1m
-5.3+1.2-6.6+0.4-5.8
2m
+7.1+7.9-0.8+5.2+1.9
3m
+9.9+10.3-0.3+3.1+6.9
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NCLT Chennai Bench passed an order on May 5, 2026, allowing a joint application by Dr. Agarwal's Eye Hospital Limited (AEHL) and Dr. Agarwal's Health Care Limited (AHCL) for amalgamation. The tribunal directed both companies to convene meetings of their equity shareholders, secured creditors, and unsecured creditors on July 2, 2026, to consider and approve the scheme of amalgamation. The certified copy of the order is awaited. The amalgamation remains subject to necessary statutory and regulatory approvals after the meetings.

Likely market impact

This is a procedural step in the amalgamation process. Shareholder and creditor approvals at the meetings, followed by final regulatory clearances, will determine the scheme's success. The stock may see movement on speculation of consolidation benefits once meetings approach.